All Disease Treatment & Prevention articles – Page 4
-
NewsChiba University and Noguchi Memorial Institute for Medical Research partnership targets next-generation vaccines
Chiba University and the University of Ghana’s Noguchi Memorial Institute for Medical Research have launched a new research partnership aimed at advancing next-generation vaccines, therapeutics and diagnostics. The collaboration will connect expertise in Japan and Ghana to strengthen infectious disease research, researcher training and global health innovation.
-
NewsAmerican Academy of Pediatrics warns of dangers in consuming raw dairy products
Updated guidance warns that raw milk and other unpasteurized dairy products can expose children and pregnant people to serious infections, with H5N1 now emerging as an additional concern. Experts say pasteurisation provides the same nutritional benefits while dramatically reducing the risk from harmful bacteria and viruses.
-
NewsEye-eating amoeba resists treatment — understanding its biochemistry could help
Acanthamoeba causes infections in the eye or brain that can lead to blindness or death. New research into the amoeba’s mitochondrial metabolism could lead to safer, more effective treatments.
-
NewsGermany marks first CRISPR therapy success
A 19-year-old with severe beta-thalassemia has become the first patient in Germany to receive an approved CRISPR-based therapy as part of routine medical care. Four months after treatment at Charité, he no longer requires regular blood transfusions, marking a major step in bringing gene editing from the laboratory into everyday clinical practice.
-
NewsHow gut bacteria can shape the brain’s response to stroke
How much damage a stroke causes in the brain depends strongly on how quickly blood flow can be restored. The patient’s own immune response that follows the stroke also plays an important role. Researchers have identified a specific bacterial signal that shapes this immune response and influences stroke outcome.
-
NewsHost immune status is significantly associated with herpesvirus retinitis phenotypes and clinical outcomes
The clinical progression and outcomes of two major herpesvirus retinitis forms are associated with patients’ immune status, reveal scientists. They evaluated the clinical symptoms at presentation, retinal detachment patterns, treatment strategies, and clinical outcomes of acute retinal necrosis and cytomegalovirus retinitis.
-
NewsViral infections can accelerate the progression of ALS, researchers find
A new study suggests that common viral infections — like influenza or COVID-19 — may accelerate the onset and progression of amyotrophic lateral sclerosis, or ALS. The findings suggest that it is the immune response triggered by these infections that accelerates the onset and progression of ALS.
-
NewsBlueberries modify gut microbiome in older adults with mild depression
A new pilot study has found that older, sedentary adults who consumed blueberries daily showed a greater, more consistent reduction in depressive symptoms, paired with minor changes in markers of gut microbial enzymes.
-
NewsGut enzyme links microbiota, barrier dysfunction and MASH progression
Metabolic dysfunction-associated steatohepatitis (MASH) is often viewed through the lens of hepatic lipid accumulation, inflammation and fibrosis. A new study identifies intestinal neutral ceramidase as a gut-derived driver of MASH progression through its effects on microbial metabolism, epithelial signalling and intestinal barrier function.
-
News Distinct gut microbiome patterns found in 5 cancer groups and in early-onset cancers
Researchers have discovered distinct gut microbiome patterns in adults 50 or younger with colorectal and breast cancers compared with those diagnosed later in life — one of several findings from an analysis of stool samples from 1,364 patients with cancer across cancer types, stages and treatments.
-
NewsResearchers develop AI tool that reveals hidden clues in the gut microbiome
Researchers are using artificial intelligence to uncover hidden clues among the trillions of bacteria living in the human gut, including changes that could one day help scientists detect diseases earlier.
-
NewsResearchers identify new vaccine target in malaria parasite
Researchers identified a previously uncharacterized site on the parasite’s major surface protein that antibodies can target to block liver infection, potentially preventing the dormant forms responsible for malaria relapses.
-
NewsDrug helps bladder cells to clear urinary infections
Researchers have identified a way to strengthen the bladder cells’ ability to eliminate urinary tract infection bacteria sheltered in the cells of the epiithelium. The drug OM-89, marketed as Uro-Vaxom®, activates cellular degradation pathways in bladder epithelial cells while also increasing the amount of antibiotic that enters them.
-
NewsGut bacteria-derived metabolite contributes to host lifespan extension
Researchers use genetically engineered Escherichia coli to reveal how gut bacteria-derived polyamines extend the lifespan of fruit flies.
-
NewsA shorter, better-tolerated treatment for chagas disease is possible
A 30-day course of benznidazole taken once a day could offer people with chronic Trypanosoma cruzi infection a safer and more practical option than the current standard treatment, taken twice a day for 60 days.
-
NewsTarget identified in treatment of neuroHIV
NeuroHIV occurs when HIV infection affects the function and structural integrity of the brain and, to some extent, the spinal cord and peripheral nervous system. New research has identified a brain protein driving this damage, pointing toward a possible treatment.
-
NewsCould these pills help people with anorexia? A new study aims to find out
A new clinical trial is recruiting people diagnosed with anorexia nervosa as researchers hope to discover if fecal microbiota transplant (FMT) capsules could help better manage this eating disorder.
-
NewsGut microbiome development may help predict type 1 diabetes in children at high risk
A new prospective study found that children at high genetic risk of type 1 diabetes whose gut microbiome development plateaued early had about three times the risk of developing the disease compared with children whose microbiomes continued to mature.
-
NewsBoosted BCG vaccine strategy significantly reduces tuberculosis relapse
A new study reveals that combining an immunotherapy with the traditional Bacille Calmette-Guérin (BCG) vaccine drastically lowers the risk of TB relapse in preclinical models.
-
NewsA tiny bacterium with a huge impact
Researchers have discovered that gut bacteria and the compounds they produce trigger biological processes that the human body on its own can only activate with difficulty. They help suppress inflammation and may also have beneficial effects on fatty liver disease.